← peptides typeshit

UCLA Health builds an algorithm to help doctors pick semaglutide or resmetirom for MASH

The review weighs the two FDA-approved MASH drugs, which haven't been tested head to head, and notes some patients may do well on both.

Read at UCLA Health

Recap by typeshit. Full story at UCLA Health.